Literatur
- 1
Weber W A, Ott K, Becker K. et al .
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric
Junction by Metabolic Imaging.
J Clin Oncol.
2001;
19
3058-3065
- 2
Grundei T, Vogelsang H, Ott K. et al .
Loss of Heterozygosity and Microsatellite Instability as Predictive Markers for Neoadjuvant
Treatment in Gastric Carcinoma.
- 3
Ott K, Vogelsang H, Mueller J. et al .
Chromosomal Instability rather than p53 Mutation is Associated with Response to Neoadjuvant
Cisplatin-Based Chemotherapy in Gastric Carcinoma.
Clin Cancer Res.
accepted, 2002
H. Vogelsang
Chrirurgische Klinik und Abteilung für Pathologie der TU München am Klinikum rechts
der Isar
Ismaninger Str. 22
81675 München
